Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Amortization - Intangibles (2016 - 2018)

Celldex Therapeutics (CLDX) has 9 years of Amortization - Intangibles data on record, last reported at $224000.0 in Q1 2018.

  • For Q1 2018, Amortization - Intangibles changed 0.0% year-over-year to $224000.0; the TTM value through Dec 2018 reached $224000.0, down 75.0%, while the annual FY2018 figure was $224000.0, 75.0% down from the prior year.
  • Amortization - Intangibles reached $224000.0 in Q1 2018 per CLDX's latest filing, roughly flat from $224000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $254000.0 in Q2 2014 and bottomed at $224000.0 in Q1 2017.
  • Average Amortization - Intangibles over 5 years is $243764.7, with a median of $253000.0 recorded in 2014.
  • Peak YoY movement for Amortization - Intangibles: increased 0.4% in 2015, then fell 11.81% in 2017.
  • A 5-year view of Amortization - Intangibles shows it stood at $252000.0 in 2014, then grew by 0.4% to $253000.0 in 2015, then dropped by 6.72% to $236000.0 in 2016, then fell by 5.08% to $224000.0 in 2017, then changed by 0.0% to $224000.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Amortization - Intangibles were $224000.0 in Q1 2018, $224000.0 in Q4 2017, and $224000.0 in Q3 2017.